These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34246753)

  • 1. Improved correction of F508del-CFTR biogenesis with a folding facilitator and an inhibitor of protein ubiquitination.
    Goeckeler-Fried JL; Aldrin Denny R; Joshi D; Hill C; Larsen MB; Chiang AN; Frizzell RA; Wipf P; Sorscher EJ; Brodsky JL
    Bioorg Med Chem Lett; 2021 Sep; 48():128243. PubMed ID: 34246753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    Chung WJ; Goeckeler-Fried JL; Havasi V; Chiang A; Rowe SM; Plyler ZE; Hong JS; Mazur M; Piazza GA; Keeton AB; White EL; Rasmussen L; Weissman AM; Denny RA; Brodsky JL; Sorscher EJ
    PLoS One; 2016; 11(10):e0163615. PubMed ID: 27732613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants.
    Borgo C; D'Amore C; Capurro V; Tomati V; Sondo E; Cresta F; Castellani C; Pedemonte N; Salvi M
    Cell Mol Life Sci; 2022 Mar; 79(4):192. PubMed ID: 35292885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment.
    Capurro V; Tomati V; Sondo E; Renda M; Borrelli A; Pastorino C; Guidone D; Venturini A; Giraudo A; Mandrup Bertozzi S; Musante I; Bertozzi F; Bandiera T; Zara F; Galietta LJV; Pedemonte N
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222.
    Singh AK; Fan Y; Balut C; Alani S; Manelli AM; Swensen AM; Jia Y; Neelands TR; Vortherms TA; Liu B; Searle XB; Wang X; Gao W; Hwang TC; Ren HY; Cyr D; Kym PR; Conrath K; Tse C
    J Pharmacol Exp Ther; 2020 Jan; 372(1):107-118. PubMed ID: 31732698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways.
    Ahner A; Gong X; Frizzell RA
    FEBS J; 2013 Sep; 280(18):4430-8. PubMed ID: 23809253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination.
    Veit G; Roldan A; Hancock MA; Da Fonte DF; Xu H; Hussein M; Frenkiel S; Matouk E; Velkov T; Lukacs GL
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32853178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview on chemical structures as ΔF508-CFTR correctors.
    Spanò V; Montalbano A; Carbone A; Scudieri P; Galietta LJV; Barraja P
    Eur J Med Chem; 2019 Oct; 180():430-448. PubMed ID: 31326599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of the Hsp70-specific nucleotide-exchange factor BAG3 corrects the F508del-CFTR variant by restoring autophagy.
    Hutt DM; Mishra SK; Roth DM; Larsen MB; Angles F; Frizzell RA; Balch WE
    J Biol Chem; 2018 Aug; 293(35):13682-13695. PubMed ID: 29986884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis.
    Brandas C; Ludovico A; Parodi A; Moran O; Millo E; Cichero E; Baroni D
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.
    Yu W; Kim Chiaw P; Bear CE
    J Biol Chem; 2011 Jul; 286(28):24714-25. PubMed ID: 21602569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1.
    Ren HY; Grove DE; De La Rosa O; Houck SA; Sopha P; Van Goor F; Hoffman BJ; Cyr DM
    Mol Biol Cell; 2013 Oct; 24(19):3016-24. PubMed ID: 23924900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.
    Amico G; Brandas C; Moran O; Baroni D
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.
    Estabrooks S; Brodsky JL
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors.
    Saint-Criq V; Wang Y; Delpiano L; Lin J; Sheppard DN; Gray MA
    J Cyst Fibros; 2021 Sep; 20(5):843-850. PubMed ID: 34020896
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zaman K; Knight J; Hussain F; Cao R; Estabrooks SK; Altawallbeh G; Holloway K; Jafri A; Sawczak V; Li Y; Getsy P; Sun F; Raffay T; Cotton C; Brodsky JL; Periasamy A; Lewis SJ; Gaston B
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):765-775. PubMed ID: 31596601
    [No Abstract]   [Full Text] [Related]  

  • 17. Cystic Fibrosis Transmembrane Conductance Regulator Folding Mutations Reveal Differences in Corrector Efficacy Linked to Increases in Immature Cystic Fibrosis Transmembrane Conductance Regulator Expression.
    Peters KW; Gong X; Frizzell RA
    Front Physiol; 2021; 12():695767. PubMed ID: 34764878
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenylhydrazones as Correctors of a Mutant Cystic Fibrosis Transmembrane Conductance Regulator.
    Nieddu E; Pollarolo B; Mazzei MT; Anzaldi M; Schenone S; Pedemonte N; Galietta LJ; Mazzei M
    Arch Pharm (Weinheim); 2016 Feb; 349(2):112-23. PubMed ID: 26701662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite regulation of F508del-CFTR biogenesis by four poly-lysine ubiquitin chains In vitro.
    Wu Q; Henri YT; Yao R; Yu L; Zhang B; Wang Z; Ma X; Zhao G; Hou X
    Biochim Biophys Acta Proteins Proteom; 2022 Jun; 1870(6):140792. PubMed ID: 35569794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770.
    Gentzsch M; Ren HY; Houck SA; Quinney NL; Cholon DM; Sopha P; Chaudhry IG; Das J; Dokholyan NV; Randell SH; Cyr DM
    Am J Physiol Lung Cell Mol Physiol; 2016 Sep; 311(3):L550-9. PubMed ID: 27402691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.